- Severe spasticity is spasticity that is problematic, interfering with comfort, function, or caregiving1
- Even seemingly mild cases of spasticity may be considered severe when they interfere with daily activities, such as dressing or bathing1-2
- 1.1 million people are affected by severe spasticity2
- Assessment of spasticity should encompass physical, functional, and quality of life measures. Since severe spasticity is based on functional limitations and comfort, severity of spasticity should be evaluated in terms of functional limitations to a patient, rather than just a numerical rating on an assessment scale—even mild degrees of spasticity can have severe consequences on patients or caregivers3
Lioresal® Intrathecal (baclofen injection) is contraindicated in patients who are hypersensitive to baclofen. Implantation of the infusion system is contraindicated if the patient is of insufficient body size, requires a pump implant deeper than 2.5 cm, or, in the presence of spinal anomalies or active infection.
- Saulino M, Ivanhoe CB, McGuire JR, et al. Best Practices for Intrathecal Baclofen Therapy: Patient Selection. Neuromodulation. 2016;19(6):607-615.
- McGuire JR. Chapter 2: Epidemiology of spasticity in the adult and child. In: Brashear A, Elovic E, eds. Spasticity: Diagnosis and Management. 2nd ed. New York, NY: Demos Medical, 2016.
- Spasticity. National Multiple Sclerosis Society website. https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms/Spasticity. Accessed December 7, 2016.